Gilead Sciences, Inc. (GILD): A Bull Case Theory

We came across a bullish thesis on Gilead Sciences, Inc. (GILD) on Substack by Disruptive analytics. In this article, we will summarize the bulls’ thesis on GILD. Gilead Sciences, Inc. (GILD)'s share was trading at $104.08 as of Feb 14^th. GILD’s trailing and forward P/E were 273.89 and 13.37 respectively according to Yahoo Finance.

[caption id="attachment_1211421" align="aligncenter" width="768"] A close-up of a human hand holding a test tube with a blue liquid, representing the biopharmaceutical company's research and development of new medicines.[/caption]

Gilead Sciences...